Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.280
-0.050 (-3.76%)
Feb 18, 2026, 1:12 PM EST - Market open
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $90.5 million as of February 18, 2026. Its market cap has decreased by -40.25% in one year.
Market Cap
90.50M
Enterprise Value
54.27M
1-Year Change
-40.25%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $90.50M, a decrease of -81.49%. That is a compound annual growth rate of -29.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 94.04M | 7.26% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 95.60M |
| Vivani Medical | 94.23M |
| Anixa Biosciences | 94.13M |
| Precision BioSciences | 93.64M |
| Verrica Pharmaceuticals | 90.98M |
| OKYO Pharma | 89.90M |
| aTyr Pharma | 87.59M |
| eXoZymes | 85.87M |